Study: Generic drugs could offer significant Medicaid savings

A new study from the Generic Pharmaceutical Association found that every 2-percent increase in substitution of generic drugs saves Medicaid $1 billion a year (Source: “GPhA Report: Generics Offer Big Medicaid Savings Opportunity,” Wall Street Journal Health Blog, July 26, 2010).

Furthermore, “Savings Achieved Through the Use of Generic Pharmaceuticals, 2000-2009” (pdf, 9 pages) found that the generic utilization rate in Medicaid is about 64 percent, more than 10 percentage points lower than the general population, which means significant savings are realistic, the study authors contend.

Attend HPIO's 2025 Health Policy Summit on Oct. 9, 2025

With limited resources and growing need, investing in policies that deliver the greatest impact is essential. This event will highlight strategies that improve health and wellbeing while reducing healthcare spending. Speakers will provide evidence-informed research responsive to today’s political climate, focusing on what works and why it matters now more than ever.

Register now